haloperidol has been researched along with 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audinot, V; Bervoets, K; Brocco, M; Canton, H; Gobert, A; Le Marouille-Girardon, S; Millan, MJ; Peglion, JL | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for haloperidol and 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine
| Article | Year |
|---|---|
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Male; Piperazines; Rats; Rats, Wistar; Serotonin Antagonists; Structure-Activity Relationship | 1995 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |